Analyst Consensus ?
ConsensusHold50 ratings
Bullish2958.0%
Neutral1836.0%
Bearish36.0%
The Charles Schwab Corporation · SCHW · FY2024 Q3 · Calendar Q4 2024
Schwab raises 2024 revenue outlook as assets and advisory flows strengthen
The call provides evidence for a constructive growth trajectory: former Ameritrade clients are supporting asset flows, advisory demand is strong, lending is expanding, and expense synergies are progressing. The main counterweights are rate-sensitive net interest income, cash-flow uncertainty, and the need to reduce supplemental funding.
Reported Before market openNYSEFinancial Services
$168.17B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.77
Consensus $0.75
EPS surprise
+2.7%
Reported versus consensus
Reported revenue
$-6.18B
Consensus $4.78B
Revenue surprise
-229.3%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+6.1%
Event window
SPY move
-0.8%
Same window
Abnormal move
+6.9%
Stock minus SPY
Volume
2.9×
Versus trailing sessions
Subsequent drift
+8.7%
Up to 20 sessions
SCHWSPY benchmark
Ask FN2 about SCHW FY2024 Q3
Transcript, numbers and history already loaded
Why did SCHW rise 6.1% after beating EPS estimates in FY2024 Q3?What changed in SCHW's guidance and outlook in FY2024 Q3?Give me the bull and bear case for SCHW after FY2024 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, management raised full-year 2024 revenue-growth guidance and reported continued progress in client adoption, advisory flows, lending, and supplemental-borrowing reduction. The remaining debate shifted toward cash-flow sustainability, net interest margin, and the timing of capital returns.
Guidance delta
Management raised full-year 2024 revenue-growth guidance to 2%–3%; the 2025 outlook remained positive despite rate uncertainty.
Key takeaways
- Q3 performance exceeded expectations, with revenue growth and adjusted EPS of $0.77.
- Net new assets are returning toward the historic 5%–7% organic-growth range as former Ameritrade clients adopt Schwab.
- Advisory flows and Pledged Asset Line balances grew, while supplemental borrowing continued to decline.
Management priorities
- Complete the remaining Ameritrade expense synergies by year-end.
- Expand wealth-management, advisory, and lending offerings, including digital loan origination.
- Build capital while preparing for future dividends, preferred redemptions, and eventual buybacks.
Follow SCHW with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$96.7Previous close
$56Low
$104.86Average
$145High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 12, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 9, 2026 |
| UBS | Buy | Buy | Maintain | Oct 7, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 7, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Oct 5, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Oct 2, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 23, 2026 |
| BMO Capital | Market Perform | Outperform | Downgrade | Jul 20, 2026 |
| TD Cowen | Buy | Buy | Maintain | May 15, 2026 |
| Raymond James | Outperform | Outperform | Maintain | May 15, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 17, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 6, 2026 |
| Truist Securities | Buy | Buy | Maintain | Apr 1, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jan 12, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Oct 17, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 17, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Oct 17, 2025 |
| Citizens Capital Markets | Market Perform | Market Perform | Maintain | Jul 21, 2025 |
| Citigroup | Buy | Buy | Maintain | Jul 21, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 11, 2025 |
| Redburn Atlantic | Neutral | Sell | Upgrade | Jun 9, 2025 |
| TD Securities | Buy | Buy | Maintain | May 20, 2025 |
| Goldman Sachs | Buy | Neutral | Upgrade | Apr 25, 2025 |
| Wolfe Research | Outperform | Outperform | Maintain | Jun 26, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | May 5, 2023 |
| Redburn Partners | Sell | Neutral | Downgrade | Apr 20, 2023 |
| Erste Group | Buy | Hold | Upgrade | Oct 5, 2022 |
| Compass Point | Buy | Neutral | Upgrade | Apr 12, 2022 |
| Atlantic Equities | Overweight | Overweight | Maintain | Oct 5, 2021 |
| CFRA | Buy | Buy | Maintain | Apr 15, 2020 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Jul 12, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Jul 12, 2019 |
| Bernstein | Perform | Market Perform | Maintain | Apr 10, 2018 |
| Nomura Instinet | Neutral | Buy | Downgrade | Jul 24, 2017 |
| Instinet | Neutral | Buy | Downgrade | Jul 24, 2017 |
| Rosenblatt | Neutral | Neutral | Maintain | Jul 13, 2017 |
| SunTrust Robinson Humphrey | Buy | Hold | Upgrade | Dec 19, 2016 |
| CLSA | Outperform | Outperform | Maintain | Sep 22, 2016 |
| Nomura | Buy | Buy | Maintain | Jul 11, 2016 |
| Argus | Buy | Buy | Maintain | Mar 23, 2016 |
| PiperJaffray | Neutral | Overweight | Downgrade | Dec 18, 2015 |
| RBC Capital | Outperform | Outperform | Maintain | Mar 27, 2015 |
| Evercore Partners | Equal Weight | Underweight | Upgrade | Dec 16, 2013 |
| Evercore ISI Group | Equal Weight | Underweight | Upgrade | Dec 16, 2013 |
| ISI Group | Buy | Buy | Maintain | May 15, 2013 |
| Sterne Agee | Neutral | Neutral | Maintain | Mar 14, 2013 |
| BGB Securities | Sell | Sell | Maintain | Jul 13, 2012 |
| Topeka Capital | Hold | Hold | Maintain | Jul 11, 2012 |
| Topeka | Hold | Hold | Maintain | Jul 11, 2012 |
| Stifel Nicolaus | Hold | Hold | Maintain | Apr 24, 2012 |
| Stifel | Hold | Buy | Downgrade | Apr 24, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $96.7. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Michael Cyprys | $141 | $96.87 | +45.8% | Oct 9, 2026 |
| Barclays | Analyst unavailable | $118 | $96.8 | +22.0% | Oct 7, 2026 |
| UBS | Analyst unavailable | $113 | $96.8 | +16.9% | Oct 7, 2026 |
| Loop Capital Markets | Analyst unavailable | $95 | $96.7 | -1.8% | Oct 5, 2026 |
| Wells Fargo | Daniel Welden | $105 | $98.37 | +8.6% | Oct 1, 2026 |
| UBS | Analyst unavailable | $135 | $105.24 | +39.6% | Aug 3, 2026 |
| Compass Point | Ed Engel | $135 | $105.24 | +39.6% | Aug 3, 2026 |
| Morgan Stanley | Michael Cyprys | $136 | $103.9 | +40.6% | Jul 27, 2026 |
| Argus Research | Stephen Biggar | $114 | $102.18 | +17.9% | Jul 23, 2026 |
| Raymond James | Patrick O'Shaughnessy | $145 | $99.79 | +49.9% | Jul 22, 2026 |
| UBS | Michael Brown | $128 | $99.96 | +32.4% | Jul 22, 2026 |
| Wolfe Research | Steven Chubak | $127 | $99.96 | +31.3% | Jul 21, 2026 |
| Piper Sandler | Analyst unavailable | $118 | $100.58 | +22.0% | Jul 21, 2026 |
| BMO Capital | Analyst unavailable | $105 | $101.56 | +8.6% | Jul 20, 2026 |
| Piper Sandler | Analyst unavailable | $112 | $101.1 | +15.8% | Jul 15, 2026 |
| Morgan Stanley | Analyst unavailable | $133 | $102.47 | +37.5% | Jul 10, 2026 |
| Barclays | Benjamin Budish | $122 | $102.19 | +26.2% | Jul 9, 2026 |
| UBS | Analyst unavailable | $122 | $102.79 | +26.2% | Jul 8, 2026 |
| Raymond James | Patrick O'Shaughnessy | $137 | $92.21 | +41.7% | May 15, 2026 |
| Deutsche Bank | Analyst unavailable | $128 | $92.61 | +32.4% | May 15, 2026 |
| Barclays | Analyst unavailable | $127 | $89.44 | +31.3% | May 15, 2026 |
| Argus Research | Analyst unavailable | $108 | $93.15 | +11.7% | Apr 20, 2026 |
| Morgan Stanley | Michael Cyprys | $125 | $91.22 | +29.3% | Apr 17, 2026 |
| Deutsche Bank | Analyst unavailable | $127 | $92.62 | +31.3% | Apr 17, 2026 |
| Morgan Stanley | Analyst unavailable | $135 | $94.27 | +39.6% | Apr 10, 2026 |
| Barclays | Benjamin Budish | $126 | $102.18 | +30.3% | Jan 26, 2026 |
| Deutsche Bank | Analyst unavailable | $131 | $104.87 | +35.5% | Jan 22, 2026 |
| Truist Financial | Analyst unavailable | $122 | $104.27 | +26.2% | Jan 22, 2026 |
| UBS | Analyst unavailable | $125 | $101.79 | +29.3% | Jan 22, 2026 |
| Barclays | Benjamin Budish | $125 | $101.79 | +29.3% | Jan 22, 2026 |
| Piper Sandler | Analyst unavailable | $105 | $101.18 | +8.6% | Jan 14, 2026 |
| Wolfe Research | Analyst unavailable | $120 | $100.17 | +24.1% | Jan 12, 2026 |
| Barclays | Analyst unavailable | $120 | $101.93 | +24.1% | Jan 8, 2026 |
| Wolfe Research | Analyst unavailable | $122 | $102.92 | +26.2% | Jan 7, 2026 |
| UBS | Analyst unavailable | $123 | $102.88 | +27.2% | Jan 7, 2026 |
| Truist Financial | Analyst unavailable | $120 | $103.57 | +24.1% | Jan 7, 2026 |
| Raymond James | Patrick O'Shaughnessy | $114 | $104.02 | +17.9% | Jan 5, 2026 |
| Morgan Stanley | Analyst unavailable | $148 | $98.82 | +53.1% | Dec 22, 2025 |
| Barclays | Analyst unavailable | $111 | $97.02 | +14.8% | Dec 12, 2025 |
| UBS | Michael Brown | $119 | $95.81 | +23.1% | Dec 11, 2025 |
| Morgan Stanley | Analyst unavailable | $139 | $93.73 | +43.7% | Nov 3, 2025 |
| Truist Financial | Analyst unavailable | $113 | $93.41 | +16.9% | Oct 17, 2025 |
| Goldman Sachs | Analyst unavailable | $114 | $93.41 | +17.9% | Oct 17, 2025 |
| Deutsche Bank | Brian Bedell | $120 | $93.41 | +24.1% | Oct 17, 2025 |
| Barclays | Analyst unavailable | $114 | $94.01 | +17.9% | Oct 8, 2025 |
| Truist Financial | Analyst unavailable | $112 | $92.49 | +15.8% | Oct 2, 2025 |
| Morgan Stanley | Michael Cyprys | $130 | $92.81 | +34.4% | Oct 1, 2025 |
| Deutsche Bank | Analyst unavailable | $113 | $91.03 | +16.9% | Sep 16, 2025 |
| Raymond James | Patrick O\'Shaughnessy | $99 | $95.25 | +2.4% | Jul 18, 2025 |
| Wells Fargo | Michael Brown | $102 | $93.1 | +5.5% | Jul 18, 2025 |
| Piper Sandler | Patrick Moley | $70 | $72.26 | -27.6% | Jan 7, 2025 |
| Barclays | Benjamin Budish | $95 | $81.47 | -1.8% | Dec 9, 2024 |
| Jefferies | Daniel Fannon | $84 | $71.96 | -13.1% | Oct 16, 2024 |
| Goldman Sachs | Alexander Blostein | $74 | $71.96 | -23.5% | Oct 16, 2024 |
| Morgan Stanley | Michael Cyprys | $68 | $71.96 | -29.7% | Oct 15, 2024 |
| JMP Securities | Devin Ryan | $84 | $71.96 | -13.1% | Oct 15, 2024 |
| JMP Securities | Devin Ryan | $82 | $64.75 | -15.2% | Jul 23, 2024 |
| Jefferies | Daniel Fannon | $88 | $73.39 | -9.0% | Jul 8, 2024 |
| Deutsche Bank | Brian Bedell | $81 | $72.54 | -16.2% | Jun 18, 2024 |
| Barclays | Benjamin Budish | $72 | $72.27 | -25.5% | May 27, 2024 |
| Barclays | Benjamin Budish | $75 | $72.34 | -22.4% | May 23, 2024 |
| Deutsche Bank | Brian Bedell | $83 | $72.65 | -14.2% | May 23, 2024 |
| Goldman Sachs | Alexander Blostein | $75 | $75.27 | -22.4% | May 23, 2024 |
| UBS | Brennan Hawken | $91 | $75.27 | -5.9% | May 23, 2024 |
| Piper Sandler | Patrick Moley | $85 | $71.23 | -12.1% | Apr 16, 2024 |
| Goldman Sachs | Alexander Blostein | $76 | $71.23 | -21.4% | Apr 16, 2024 |
| Wolfe Research | Steven Chubak | $84 | $72.33 | -13.1% | Apr 15, 2024 |
| Goldman Sachs | Alexander Blostein | $72 | $72.48 | -25.5% | Apr 15, 2024 |
| Morgan Stanley | Michael Cyprys | $71 | $72.37 | -26.6% | Apr 9, 2024 |
| Barclays | Benjamin Budish | $74 | $71.89 | -23.5% | Apr 8, 2024 |
| Deutsche Bank | Brian Bedell | $77 | $68.35 | -20.4% | Mar 19, 2024 |
| Wolfe Research | Steven Chubak | $74 | $67.4 | -23.5% | Mar 18, 2024 |
| JMP Securities | Devin Ryan | $73 | $57.38 | -24.5% | Jul 10, 2023 |
| Credit Suisse | Bill Katz | $66.5 | $54.06 | -31.2% | Apr 18, 2023 |
| Barclays | Charles Schwab | $56 | $50.77 | -42.1% | Apr 14, 2023 |
| Credit Suisse | Bill Katz | $67.5 | $56.68 | -30.2% | Mar 15, 2023 |
| UBS | Analyst unavailable | $97 | $85.98 | +0.3% | Jan 9, 2023 |
| Barclays | Analyst unavailable | $83 | $78.19 | -14.2% | Dec 19, 2022 |
| Deutsche Bank | Analyst unavailable | $101 | $78.58 | +4.4% | Nov 15, 2022 |
| Deutsche Bank | Brian Bedell | $80 | $63.39 | -17.3% | Jul 5, 2022 |
| Deutsche Bank | Brian Bedell | $84 | $63.28 | -13.1% | May 23, 2022 |
| Deutsche Bank | Brian Bedell | $98 | $68.54 | +1.3% | Apr 27, 2022 |
| Morgan Stanley | Analyst unavailable | $123 | $69.95 | +27.2% | Apr 25, 2022 |
| Deutsche Bank | Brian Bedell | $111 | $70.32 | +14.8% | Apr 25, 2022 |
| UBS | Brennan Hawken | $72 | $70.32 | -25.5% | Apr 24, 2022 |
| Citigroup | Analyst unavailable | $90 | $71.13 | -6.9% | Apr 22, 2022 |
| Piper Sandler | Analyst unavailable | $100 | $73.27 | +3.4% | Apr 22, 2022 |
| Morgan Stanley | Michael Cyprys | $132 | $77.59 | +36.5% | Apr 21, 2022 |
| Compass Point | Chris Allen | $98 | $82.75 | +1.3% | Apr 16, 2022 |
| Deutsche Bank | Brian Bedell | $114 | $81.58 | +17.9% | Apr 11, 2022 |
| Goldman Sachs | Will Nance | $100 | $81.69 | +3.4% | Apr 8, 2022 |
| Piper Sandler | Richard Repetto | $110 | $81.69 | +13.8% | Apr 8, 2022 |
| Bank of America Securities | Craig Siegenthaler | $112 | $81.86 | +15.8% | Apr 5, 2022 |
| Deutsche Bank | Brian Bedell | $122 | $95.53 | +26.2% | Jan 17, 2022 |
| UBS | Brennan Hawken | $90 | $89.77 | -6.9% | Jan 4, 2022 |
| Wolfe Research | Steven Chubak | $90 | $83.19 | -6.9% | Oct 22, 2021 |
| Atlantic Equities | John Heagerty | $95 | $75.57 | -1.8% | Oct 5, 2021 |
| Compass Point | Christopher Allen | $75 | $74.1 | -22.4% | Oct 1, 2021 |
| Wells Fargo | Christopher Harris | $88 | $74.42 | -9.0% | Jun 2, 2021 |
| Barclays | Jeremy Campbell | $70 | $66.51 | -27.6% | Apr 23, 2021 |
Track every rating change on SCHW the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationThe Charles Schwab Corporation (SCHW) stands as a prominent financial services enterprise, delivering a comprehensive suite of offerings that encompass wealth management, securities trading and brokerage, banking services, asset administration, custodial solutions, and financial planning advice. Its operations are primarily structured around two core divisions: Investor Services and Advisor Services. The Investor Services segment caters directly to individual retail clients, furnishing a range of services such as brokerage accounts, investment guidance, banking and trust administration, retirement planning, and corporate brokerage offerings. It further assists businesses with the full-service recordkeeping of equity compensation plans (e.g., stock options, restricted stock, performance shares), provides clearing services for retail investors and mutual funds, and offers compliance solutions. Conversely, the Advisor Services segment provides a robust support system for independent investment advisors.…
Historical context
All SCHW earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FDS FactSet Research Systems Inc. | FY2026 Q4 · Calendar Q3 2026 | +3.9% | +3.8% | FactSet reports record FY26 results as AI and MCP adoption accelerate |
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
Latest beats and misses
Who reports nextBeat on EPS
Get the SCHW recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-10-17T05:10:49.140638+00:00
- Polygon adjusted daily market bars · 2026-10-12T09:50:44.138060+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-12T09:50:44.135103+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-12. For educational purposes only; not investment advice.